• 1
    Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 33073318.
  • 2
    Studeny M, Marini FC, Dembinski JL et al. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96: 15931603.
  • 3
    Sasaki M, Abe R, Fujita Y et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008; 180: 25812587.
  • 4
    Satake K, Lou J, Lenke LG. Migration of mesenchymal stem cells through cerebrospinal fluid into injured spinal cord tissue. Spine 2004; 29: 19711979.
  • 5
    Neuhuber B, Timothy Himes B, Shumsky JS et al. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 2005; 1035: 7385.
  • 6
    Spaeth E, Klopp A, Dembinski J et al. Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15: 730738.
  • 7
    Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104: 22242234.
  • 8
    Okuyama H, Krishnamachary B, Zhou YF et al. Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 2006; 281: 1555415563.
  • 9
    Chen D, Zhang Z, Wu X et al. Distribution of intravenously grafted bone marrow mesenchymal stem cells in the viscera tissues of rats before, after cerebral ischemia. J Clin Rehab Tissue Eng Res 2007; 11: 1016010164.
  • 10
    Spitkovsky D, Hescheler J. Adult mesenchymal stromal stem cells for therapeutic applications. Minim Invasive Ther Allied Technol 2008; 17: 7990.
  • 11
    Klopp AH, Spaeth EL, Dembinski JL et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 2007; 67: 1168711695.
  • 12
    Mouiseddine M, Fran[cedil]ois S, Semont A et al. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol 2007; 80: S49S55.
  • 13
    Gorin NC, Fliedner TM, Gourmelon P et al. Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol 2006; 85: 671679.
  • 14
    Dvorak HF. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 16501659.
  • 15
    Wu Y, Wang J, Scott PG et al. Bone marrow-derived stem cells in wound healing: A review. Wound Repair Regen 2007; 15( suppl 1): S18S26.
  • 16
    Saito T, Kuang JQ, Bittira B et al. Xenotransplant cardiac chimera: Immune tolerance of adult stem cells. Ann Thorac Surg 2002; 74: 1924; discussion 24.
  • 17
    Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701705.
  • 18
    Jackson KA, Majka SM, Wang H et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107: 13951402.
  • 19
    Bittner RE, Schofer C, Weipoltshammer K et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 1999; 199: 391396.
  • 20
    Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309313.
  • 21
    Hofstetter CP, Schwarz EJ, Hess D et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002; 99: 21992204.
  • 22
    Bacigalupo A. Management of acute graft-versus-host disease. Br J Haematol 2007; 137: 8798.
  • 23
    Kidd S, Spaeth E, Klopp A et al. The (in) auspicious role of mesenchymal stromal cells in cancer: Be it friend or foe. Cytotherapy 2008; 10: 657667.
  • 24
    Studeny M, Marini FC, Champlin RE et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002; 62: 36033608.
  • 25
    Allers C, Sierralta WD, Neubauer S et al. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004; 78: 503508.
  • 26
    Pereira RF, Halford KW, O'Hara MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995; 92: 48574861.
  • 27
    de Wet JR, Wood KV, Helinski DR et al. Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc Natl Acad Sci U S A 1985; 82: 78707873.
  • 28
    Contag CH, Jenkins D, Contag PR et al. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2: 4152.
  • 29
    Contag CH, Spilman SD, Contag PR et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997; 66: 523531.
  • 30
    Contag CH, Bachmann MH. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002; 4: 235260.
  • 31
    Sweeney TJ, Mailänder V, Tucker AA et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 1999; 96: 1204412049.
  • 32
    Edinger M, Sweeney TJ, Tucker AA et al. Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1999; 1: 303310.
  • 33
    Azadniv M, Dugger K, Bowers WJ et al. Imaging CD8+ T cell dynamics in vivo using a transgenic luciferase reporter. Int Immunol 2007; 19: 11651173.
  • 34
    Wang X, Rosol M, Ge S et al. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 2003; 102: 34783482.
  • 35
    Cao YA, Wagers AJ, Beilhack A et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 2004; 101: 221226.
  • 36
    Min JJ, Ahn Y, Moon S et al. In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium. Ann Nucl Med 2006; 20: 165170.
  • 37
    van der Bogt KE, Sheikh AY, Schrepfer S et al. Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 2008; 118( 14 suppl): S121S129.
  • 38
    van der Bogt KE, Schrepfer S, Yu J et al. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009; 87: 642652.
  • 39
    Tögel F, Yang Y, Zhang P et al. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F315F321.
  • 40
    Love Z, Wang F, Dennis J et al. Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med 2007; 48: 20112020.
  • 41
    Hwang do W, Jang SJ, Kim YH et al. Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds. Eur J Nucl Med Mol Imaging 2008; 35: 18871898.
  • 42
    Ling X, Konopleva M, Zeng Z et al. The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res 2007; 67: 42104218.
  • 43
    Yotnda P, Zompeta C, Heslop HE et al. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses. Hum Gene Ther 2004; 15: 12291242.
  • 44
    Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315317.
  • 45
    Rabinovich BA, Ye Y, Etto T et al. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A 2008; 105: 1434214346.
  • 46
    Fischer UM, Harting MT, Jimenez F et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 2009; 18: 683692.
  • 47
    Mooney DJ, Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2008; 2: 205213.
  • 48
    Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell 2008; 132: 544548.
  • 49
    Copland IB, Lord-Dufour S, Cuerquis J et al. Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells 2009; 27: 467477.
  • 50
    Spaeth EL, Dembinski JL, Sasser AK et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009; 4: e4992.
  • 51
    Mayer-Kuckuk P, Doubrovin M, Bidaut L et al. Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cells. Cell Transplant 2006; 15: 7582.
  • 52
    Hung SC, Deng WP, Yang WK et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005; 11: 77497756.
  • 53
    Bos C, Delmas Y, Desmoulière A et al. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004; 233: 781789.
  • 54
    Wu X, Hu J, Zhou L et al. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. J Neurosurg 2008; 108: 320329.
  • 55
    Amsalem Y, Mardor Y, Feinberg MS et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007; 116( 11 suppl): I38I45.